Skip to main navigation Skip to search Skip to main content

Cardiovascular complications of Down syndrome: Scoping review and expert consensus

  • Konstantinos Dimopoulos
  • , Andrew Constantine
  • , Paul Clift
  • , Robin Condliffe
  • , Shahin Moledina
  • , Katrijn Jansen
  • , Ryo Inuzuka
  • , Gruschen R Veldtman
  • , Clifford L Cua
  • , Edgar Lik Tay
  • , Alexander R Opotowsky
  • , George Giannakoulas
  • , Rafael Alonso-Gonzalez
  • , Rachael Cordina
  • , George Capone
  • , Judith Namuyonga
  • , Charmaine H Scott
  • , Michele D'Alto
  • , Francisco J Gamero
  • , Brian Chicoine
    • Hong Gu, Alisa Limsuwan, Tosin Majekodunmi, Werner Budts, Gerry Coghlan, Craig S Broberg, Advocate Family Medicine Faculty - Lutheran General
  • Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom (K.D., A.C.).
  • Department of Cardiology, Queen Elizabeth Hospital Birmingham, United Kingdom (P.C.).
  • Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom (R.C.).
  • National Paediatric Pulmonary Hypertension Service UK, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom (S.M.).
  • Adult Congenital and Paediatric Heart Unit, Freeman Hospital Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom (K.J.).
  • Department of Pediatrics, The University of Tokyo Hospital, Japan (R.I.).
  • Scottish Adult Congenital Cardiac Service, Golden Jubilee Hospital, Glasgow, Scotland, United Kingdom (G.R.V.).
  • The Heart Center, Nationwide Children's Hospital, Columbus, OH (C.L.C.).
  • Department of Cardiology, National University Hospital Singapore (E.T.L.W.).
  • The Heart Institute, Department of Pediatrics, Cincinnati Children's Hospital, University of Cincinnati College of Medicine, OH (A.R.O.).
  • Department of Cardiology, AHEPA University Hospital School of Medicine, Aristotle University of Thessaloniki, Greece (G.G.).
  • Division of Cardiology, Toronto General Hospital, University Health Network, Peter Munk Cardiovascular Center, University of Toronto, Canada (R.A.-G.).
  • Department of Cardiology, Royal Prince Alfred Hospital and Sydney Medical School, University of Sydney, New South Wales, Australia (R.C.).
  • Down Syndrome Clinical and Research Center, Kennedy Krieger Institute, Baltimore, MD (G. Capone).
  • Department of Paediatric Cardiology, Uganda Heart Institute, Kampala (J.N.).
  • University Hospital of the West Indies, Kingston, Jamaica (C.H.S.).
  • Department of Cardiology, University "L. Vanvitelli"-Monaldi Hospital, Naples, Italy (M.D.).
  • Department of Cardiovascular Surgery, Benjamin Bloom Children's Hospital, El Salvador (F.J.G.).
  • Advocate Aurora Health
  • Department of Pediatric Cardiology, Beijing Anzhen Hospital, Capital Medical University, China (H.G.).
  • Division of Pediatric Cardiology, Department of Pediatrics, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (A.L.).
  • Department of Cardiology, Euracare Multi-specialist Hospital, Nigeria (T.M.).
  • Division of Congenital and Structural Cardiology, University Hospitals Leuven, and Department of Cardiovascular Science, Catholic University Leuven, Belgium (W.B.).
  • Department of Cardiology, Royal Free Hospital, London, United Kingdom (G. Coghlan).
  • Knight Cardiovascular Institute, Oregon Health and Science University, Portland (C.S.B.).

Research output: Contribution to journal › Article › peer-review

Abstract

Cardiovascular disease is a leading cause of morbidity and mortality in individuals with Down syndrome. Congenital heart disease is the most common cardiovascular condition in this group, present in up to 50% of people with Down syndrome and contributing to poor outcomes. Additional factors contributing to cardiovascular outcomes include pulmonary hypertension; coexistent pulmonary, endocrine, and metabolic diseases; and risk factors for atherosclerotic disease. Moreover, disparities in the cardiovascular care of people with Down syndrome compared with the general population, which vary across different geographies and health care systems, further contribute to cardiovascular mortality; this issue is often overlooked by the wider medical community. This review focuses on the diagnosis, prevalence, and management of cardiovascular disease encountered in people with Down syndrome and summarizes available evidence in 10 key areas relating to Down syndrome and cardiac disease, from prenatal diagnosis to disparities in care in areas of differing resource availability. All specialists and nonspecialist clinicians providing care for people with Down syndrome should be aware of best clinical practice in all aspects of care of this distinct population.

Original languageAmerican English
JournalCirculation
DOIs
StatusPublished - Jan 31 2023

Keywords

  • Down syndrome
  • cardiovascular diseases
  • heart defects

Access to Document

Other files and links

Cite this